References
- Sherwin T, Brookes NH. Morphological changes in keratoconus: pathology or pathogenesis. Clin Exp Ophthalmol. 2004;32(2):211–217. doi:https://doi.org/10.1111/j.1442-9071.2004.00805.x.
- Galvis V, Sherwin T, Tello A, Merayo J, Barrera R, Acera A. Keratoconus: an inflammatory disorder? Eye (Lond). 2015;29(7):843–859. doi:https://doi.org/10.1038/eye.2015.63.
- Lema I, Duran JA. Inflammatory molecules in the tears of patients with keratoconus. Ophthalmology. 2005;112(4):654–659. doi:https://doi.org/10.1016/j.ophtha.2004.11.050.
- Lema I, Sobrino T, Duran JA, Brea D, Diez-Feijoo E. Subclinical keratoconus and inflammatory molecules from tears. Br J Ophthalmol. 2009;93(6):820–824. doi:https://doi.org/10.1136/bjo.2008.144253.
- Mathew J, Goosey J, Burns A, Bergmanson J. Immunohistochemistry and ultrastructure of anterior stromal cells in keratoconus. Invest Ophthalmol Vis Sci. 2010;51:6230.
- Gaskin JCF, Loh I-P, McGhee CN, Sherwin T. An immunohistochemical study of inflammatory cell changes and matrix remodeling with and without acute hydrops in keratoconus. Invest Ophthalmol Vis Sci. 2015;56(10):5831–5837. doi:https://doi.org/10.1167/iovs.14-15123.
- Mandathara PS, Stapleton FJ, Kokkinakis J, Willcox MD. A pilot study on corneal Langerhans cells in keratoconus. Contact Lens Anterior Eye. 2017;41(2):219–223.
- Wisse RP, Kuiper JJ, Gans R, Imhof S, Radstake TR, Van der Lelij A. Cytokine expression in keratoconus and its corneal microenvironment: a systematic review. The Ocular Surface. 2015;13(4):272–283.
- Celis JE, Gromov P, Cabezón T. et al., Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol Cell Proteomics. 2004;3(4):327–344.
- Gatzioufas Z, Panos GD, Hamada S. Keratoconus: Is It a Non-inflammatory Disease? Med Hypothesis Discov Innov Ophthalmol.. 2017;6(1):1–2.
- Ionescu C, Corbu CG, Tanase C, et al. Inflammatory biomarkers profile as microenvironmental expression in keratoconus. Dis Markers. 2016;2016:1–8. doi:https://doi.org/10.1155/2016/1243819.
- McMonnies CW. Inflammation and keratoconus. Optometry Vision Sci. 2015;92(2):e35–e41. doi:https://doi.org/10.1097/OPX.0000000000000455.
- Balasubramanian SA, Mohan S, Pye DC, Willcox MDP. Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus. Acta Ophthalmol. 2012;90:4. doi:https://doi.org/10.1111/j.1755-3768.2011.02369.x.
- Kolozsvári BL, Petrovski G, Gogolák P, et al. Association between mediators in the tear fluid and the severity of keratoconus. Ophthalmic Res. 2014;51(1):46–51. doi:https://doi.org/10.1159/000351626.
- Fu-Shin XY, Yin J, Xu K, Huang J. Growth factors and corneal epithelial wound healing. Brain Res Bull. 2010;81(2–3):229–235. doi:https://doi.org/10.1016/j.brainresbull.2009.08.024.
- Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. 2000;19(1):113–129. doi:https://doi.org/10.1016/S1350-9462(99)00007-5.
- Wilson SE, Mohan RR, Mohan RR, Ambrosio R Jr., Hong J, Lee J. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res. 2001;20(5):625–637. doi:https://doi.org/10.1016/S1350-9462(01)00008-8.
- Mohan RR, Mohan RR, Kim W-J, Wilson SE. Modulation of TNF-α–induced apoptosis in corneal fibroblasts by transcription factor NF-κB. Invest Ophthalmol Vis Sci. 2000;41:1327–1336.
- Banchereau J, Briere F, Caux C, et al. Immunobiology of Dendritic Cells. Annu Rev Immunol. 2000;18(1):767–811. doi:https://doi.org/10.1146/annurev.immunol.18.1.767.
- Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic‐Canic M. Growth factors and cytokines in wound healing. Wound Repair and Regeneration. 2008;16(5):585–601. doi:https://doi.org/10.1111/j.1524-475X.2008.00410.x.
- Raja SK, Garcia MS, Isseroff RR. Wound re-epithelialization: modulating keratinocyte migration in wound healing. Front Biosci. 2007;12(2849):e68. doi:https://doi.org/10.2741/2277.
- Zhou L, Yue BY, Twining SS, Sugar J, Feder RS. Expression of wound healing and stress-related proteins in keratoconus corneas. Curr Eye Res. 1996;15(11):1124–1131. doi:https://doi.org/10.3109/02713689608995144.
- Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). Faseb J. 1990;4(11):2860–2867. doi:https://doi.org/10.1096/fasebj.4.11.2199284.
- Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83(3):835–870. doi:https://doi.org/10.1152/physrev.2003.83.3.835.
- Fràter-Schröder M, Risau W, Hallmann R, Gautschi P, Böhlen P. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc National Acad Sci. 1987;84(15):5277–5281. doi:https://doi.org/10.1073/pnas.84.15.5277.
- Tang A, Gilchrest BA. Regulation of keratinocyte growth factor gene expression in human skin fibroblasts. J Dermatol Sci. 1996;11(1):41–50. doi:https://doi.org/10.1016/0923-1811(95)00418-1.
- Mohan RR, Kim WJ, Mohan RR, Chen L, Wilson SE. Bone morphogenic proteins 2 and 4 and their receptors in the adult human cornea. Invest Ophthalmol Vis Sci. 1998;39:2626–2636.
- Saghizadeh M, Chwa M, Aoki A, et al. Altered expression of growth factors and cytokines in keratoconus, bullous keratopathy and diabetic human corneas. Exp Eye Res. 2001;73(2):179–189. doi:https://doi.org/10.1006/exer.2001.1028.
- Priyadarsini S, McKay TB, Sarker-Nag A, Karamichos D. Keratoconus in vitro and the key players of the TGF-β pathway. Mol Vis. 2015;21:577.
- Okamura T, Morita K, Iwasaki Y. et al., Role of TGF-β3 in the regulation of immune responses. Clin Exp Rheumatol. 2015;33(4 Suppl 92):63–69.
- Ferguson MW, O’Kane S. Scar–free healing: from embryonic mechanisms to adult therapeutic intervention. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2004;359(1445):839–850.
- Lee Y, Awasthi A, Yosef N. et al., Induction and molecular signature of pathogenic T H 17 cells. Nature Immunology. 2012;13(10):991.
- Qi H, Chuang EY, Yoon K-C, et al. Patterned expression of neurotrophic factors and receptors in human limbal and corneal regions. Mol Vis. 2007;13:1934–1941.
- Chen H, Weber AJ. BDNF enhances retinal ganglion cell survival in cats with optic nerve damage. Invest Ophthalmol Vis Sci. 2001;42:966–974.
- Chung ES, Lee KH, Kim M, et al. Expression of neurotrophic factors and their receptors in keratoconic cornea. Curr Eye Res. 2013;38(7):743–750. doi:https://doi.org/10.3109/02713683.2013.774421.
- Balasubramanian SA, Mohan S, Pye DC, Willcox MD. Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus. Acta Ophthalmol. 2012;90(4):e303–309.
- Kolozsvari BL, Berta A, Petrovski G, et al. Alterations of tear mediators in patients with keratoconus after corneal crosslinking associate with corneal changes. PLoS One. 2013;8(10):e76333. doi:https://doi.org/10.1371/journal.pone.0076333.
- Brookes N, Loh I-P, Clover G, Poole C, Sherwin T. Involvement of corneal nerves in the progression of keratoconus. Exp Eye Res. 2003;77(4):515–524. doi:https://doi.org/10.1016/S0014-4835(03)00148-9.
- Al-Dabbagh NM, Al-Dohayan N, Al-Asmari A, Arfin M, Tariq M Association of TNF-alpha and TNF-beta gene polymorphisms with primary open angle and primary angle closure glaucoma. The Mystery of Glaucoma. InTech; 2011.
- Dekaris I, Gabric N, Mazuran R, Karaman Z, Mravicic I. Profile of cytokines in aqueous humor from corneal graft recipients. Croat Med J. 2001;42:650–656.
- Taniguchi T, Minami Y. The IL-2IL-2 receptor system: a current overview. Cell. 1993;73(1):5–8. doi:https://doi.org/10.1016/0092-8674(93)90152-G.
- Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol. 2006;6(8):595. doi:https://doi.org/10.1038/nri1901.
- Gong YB, Lu XH, Ke XY, et al. [Effects of anti-CD25 monoclonal antibody on the level of cytokines in aqueous humour after rat penetrating keratoplasty]. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28(9):1523–1529.
- Abbas AK. The control of T cell activation vs. tolerance. Autoimmun Rev. 2003;2(3):115–118. doi:https://doi.org/10.1016/S1568-9972(03)00028-4.
- Lodolce JP, Burkett PR, Koka RM, Boone DL, Ma A. Regulation of lymphoid homeostasis by interleukin-15. Cytokine Growth Factor Rev. 2002;13(6):429–439. doi:https://doi.org/10.1016/S1359-6101(02)00029-1.
- Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3(8):917–921. doi:https://doi.org/10.1038/nm0897-917.
- Feghali CA, Wright TM. Cytokines in acute and chronic inflammation. Front Biosci. 1997;2(1):d12–d26. doi:https://doi.org/10.2741/A171.
- Volpert OV, Fong T, Koch AE, et al. Inhibition of angiogenesis by interleukin 4. Jim Exper Med. 1998;188(6):1039–1046. doi:https://doi.org/10.1084/jem.188.6.1039.
- Kumagai N, Fukuda K, Nishida T. Synergistic effect of TNF-α and IL-4 on the expression of thymus-and activation-regulated chemokine in human corneal fibroblasts. Biochem Biophys Res Commun. 2000;279(1):1–5. doi:https://doi.org/10.1006/bbrc.2000.3890.
- Soumelis V, Reche PA, Kanzler H. et al., Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP. Nature Immunology. 2002;3(7):673–680.
- Liang H, Kessal K, Rabut G. et al., Correlation of clinical symptoms and signs with conjunctival gene expression in primary Sjögren syndrome dry eye patients. The Ocular Surface. 2019;17(3):516–525.
- Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med. 1994;179(6):1895–1902. doi:https://doi.org/10.1084/jem.179.6.1895.
- Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 1966;153(3731):80–82. doi:https://doi.org/10.1126/science.153.3731.80.
- McKenna HJ, Stocking KL, Miller RE, et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood. 2000;95(11):3489–3497. doi:https://doi.org/10.1182/blood.V95.11.3489.
- Veiby OP, Jacobsen FW, Cui L, Lyman SD, Jacobsen SE. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta. J Immunol. 1996;157:2953–2960.
- Dong J, McPherson CM, Stambrook PJ. Flt-3 Ligand: a potent dendritic cell stimulator and novel antitumor. Cancer Biol Ther. 2002;1(5):486–489. doi:https://doi.org/10.4161/cbt.1.5.161.
- Shaw SG, Maung AA, Steptoe RJ, Thomson AW, Vujanovic NL. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy. J Immunol. 1998;161:2817–2824.
- Kelner GS, Kennedy J, Bacon KB, et al. Lymphotactin: A Cytokine That Represents a New Class of Chemokine. Science. 1994;266(5189):1395–1399. doi:https://doi.org/10.1126/science.7973732.
- Yamagami S, Miyazaki D, Ono SJ, Dana MR. Differential chemokine gene expression in corneal transplant rejection. Invest Ophthalmol Vis Sci. 1999;40:2892–2897.
- Wu L, Yu YL, Galiano RD, Roth SI, Mustoe TA. Macrophage colony-stimulating factor accelerates wound healing and upregulates TGF-beta1 mRNA levels through tissue macrophages. J Surg Res. 1997;72(2):162–169. doi:https://doi.org/10.1006/jsre.1997.5178.
- Warren M, Ralph P. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J Immunol. 1986;137:2281–2285.
- Phillips GD, Aukerman SL, Whitehead RA, Knighton DR. Macrophage colony-stimulating factor induces indirect angiogenesis in vivo. Wound Repair Regen. 1993;1(1):3–9. doi:https://doi.org/10.1046/j.1524-475X.1993.10104.x.
- Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol. 2008;8(7):533. doi:https://doi.org/10.1038/nri2356.
- Fillmore RA, Nelson SE, Lausch RN, Oakes JE. Differential regulation of ENA-78 and GCP-2 gene expression in human corneal keratocytes and epithelial cells. Invest Ophthalmol Vis Sci. 2003;44(8):3432–3437. doi:https://doi.org/10.1167/iovs.03-0095.
- Strieter RM, Polverini PJ, Kunkel SL, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem. 1995;270(45):27348–27357. doi:https://doi.org/10.1074/jbc.270.45.27348.
- Youn B-S, Zhang SM, Lee EK, et al. Molecular cloning of leukotactin-1: a novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3. J Immunol. 1997;159(11):5201–5205.
- Wang W, Bacon KB, Oldham ER, Schall TJ. Molecular cloning and functional characterization of human MIP-1δ, a new C–C chemokine related to mouse CCF-18 and C10. J Clin Immunol. 1998;18(3):214–222. doi:https://doi.org/10.1023/A:1020535106684.
- Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, Farber JM. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3α. J Immunol. 1999;162:186–194.
- Shirane J, Nakayama T, Nagakubo D, et al. Corneal epithelial cells and stromal keratocytes efficently produce CC chemokine-ligand 20 (CCL20) and attract cells expressing its receptor CCR6 in mouse herpetic stromal keratitis. Curr Eye Res. 2004;28(5):297–306. doi:https://doi.org/10.1076/ceyr.28.5.297.28682.
- Dana MR, Yamada J, Streilein JW. Topical Interleukin 1 receptor antagonist promotes corneal transplant Survival1. Transplantation. 1997;63(10):1501–1507. doi:https://doi.org/10.1097/00007890-199705270-00022.
- Heur M, Chaurasia SS, Wilson SE. Expression of interleukin 1 Receptor antagonist in human cornea. Exp Eye Res. 2009;88(5):992–994. doi:https://doi.org/10.1016/j.exer.2008.11.019.
- Torres P, de Vos AF, van der Gaag R, Kijlstra A. Expression of the interleukin 1 receptor antagonist in the normal human cornea. Ocul Immunol Inflamm. 1994;2(4):217–222. doi:https://doi.org/10.3109/09273949409057079.
- Lu P, Li L, Liu G, Zhang X, Mukaida N. Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist. Invest Ophthalmol Vis Sci. 2009;50(10):4761–4768. doi:https://doi.org/10.1167/iovs.08-2732.
- Fajardo LF, Kwan HH, Kowalski J, Prionas SD, Allison AC. Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol. 1992;140:539–544.
- Sainson RC, Johnston DA, Chu HC, et al. TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood. 2008;111(10):4997–5007. doi:https://doi.org/10.1182/blood-2007-08-108597.
- Bernardini G, Spinetti G, Ribatti D, et al. I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. Blood. 2000;96(13):4039–4045. doi:https://doi.org/10.1182/blood.V96.13.4039.
- Ruckes T, Saul D, Van Snick J, Hermine O, Grassmann R. Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. Blood. 2001;98(4):1150–1159. doi:https://doi.org/10.1182/blood.V98.4.1150.
- Miller MD, Krangel MS. The human cytokine I-309 is a monocyte chemoattractant. Proc National Acad Sci. 1992;89(7):2950–2954. doi:https://doi.org/10.1073/pnas.89.7.2950.
- Hu G, Riordan JF, Vallee BL. Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities. Proc Natl Acad Sci U S A. 1994;91(25):12096–12100. doi:https://doi.org/10.1073/pnas.91.25.12096.
- Lee SH, Kim KW, Joo K, Kim JC. Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts. BMC Ophthalmol. 2016;16:57.
- Bacher M, Metz CN, Calandra T, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc National Acad Sci. 1996;93(15):7849–7854.
- Ogawa H, Nishihira J, Sato Y, et al. An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine. 2000;12(4):309–314.
- White ES, Flaherty KR, Carskadon S, et al. Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. Clin Cancer Res. 2003;9(2):853–860.
- Usui T, Yamagami S, Kishimoto S, Seiich Y, Nakayama T, Amano S. Role of macrophage migration inhibitory factor in corneal neovascularization. Invest Ophthalmol Vis Sci. 2007;48:3545–3550.